THE USE OF AUTOLOGOUS FIBRINOGEN CONCENTRATE IN TREATING GLAUCOMA FILTRATION SURGERY INDUCED OCULAR HYPOTONY PATIENTS

T. Y. Liu and D. W. Lu

Department of Opthalmology, Tri-Service General Hospital, Taiwan

PURPOSE:In this study, we described the experience of using autologous fibrinogen comcentrate (AFC)to treat patients with persistent hypotony after glaucoma filtration surgery. METHODS: Among seven MMC augmented trabeculectomy patientsd who developed persistent post-operative hypotony, the effects of AFC subconjunctival injection were evaluated. The AFC was prepared by our blood bank. Under microscope,0.2 mL AFC and bovine thrombin (Thrombosat, Parke-Davis, Sydney, Australia) were injected to the blebs of these patients from both sides of conjunctiva. Postoperatively, best-corrected visual acuity, anterior chamber, intraocular pressure (IOP) and fundus examinations were followed and compared with those pre-operatively. RESULTS: On the second day after subconjunctival injection of AFC, the mean IOP elevated from 3.4  2.1 mmHg to 12.6  4.2 mmHg, and the anterior chamber became deep without obvious inflammation response. Within 2 weeks, macular edema and visual acuity were noted to improve in 6 cases (85.7%). In addition, after a mean follow-up for 25 months, the trabeculectomy procedure remained sucessful in all cases. CONCLUSIONS: AFC appeared to be safe and effective in the treatment of ocular hypotony after glaucoma filtration surgery, while the outcome of filtration surgery was not influenced.